Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Faster disease progression in Parkinson’s disease with type 2 diabetes is not associated with increased α‐synuclein, tau, amyloid‐β or vascular pathology
Authors
Keywords
-
Journal
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-05-10
DOI
10.1111/nan.12728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease
- (2020) Julia L.Y. Cheong et al. Journal of Parkinsons Disease
- Diabetes medications and risk of Parkinson’s disease: a cohort study of patients with diabetes
- (2020) Ruth Brauer et al. BRAIN
- Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
- (2019) Eduardo De Pablo-Fernández et al. JAMA Neurology
- CSF and blood biomarkers for Parkinson's disease
- (2019) Lucilla Parnetti et al. LANCET NEUROLOGY
- Interaction of amyloidogenic proteins in pancreatic β cells from subjects with synucleinopathies
- (2018) Ivan Martinez-Valbuena et al. ACTA NEUROPATHOLOGICA
- Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums
- (2018) Steven E. Arnold et al. Nature Reviews Neurology
- Diabetes mellitus and Parkinson disease
- (2018) Gennaro Pagano et al. NEUROLOGY
- Association between diabetes and subsequent Parkinson disease
- (2018) Eduardo De Pablo-Fernandez et al. NEUROLOGY
- Glucose dysregulation in Parkinson's disease: Too much glucose or not enough insulin?
- (2018) Ana Marques et al. PARKINSONISM & RELATED DISORDERS
- Detrimental effect of type 2 diabetes mellitus in a large case series of Parkinson's disease
- (2018) Seok Jong Chung et al. PARKINSONISM & RELATED DISORDERS
- Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)
- (2018) Brit Mollenhauer et al. MOVEMENT DISORDERS
- Earlier onset of motor complications in Parkinson's patients with comorbid diabetes mellitus
- (2018) Norlinah Mohamed Ibrahim et al. MOVEMENT DISORDERS
- Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson's disease
- (2017) Marissa Ong et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Diagnosis and management of dementia with Lewy bodies
- (2017) Ian G. McKeith et al. NEUROLOGY
- Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson Disease
- (2016) M. Petrou et al. ACADEMIC RADIOLOGY
- Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology
- (2016) Erin L. Abner et al. Alzheimers & Dementia
- Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment
- (2016) Olivia A. Skrobot et al. BRAIN
- Neuroendocrine abnormalities in Parkinson's disease
- (2016) Eduardo De Pablo-Fernández et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Risk of Parkinson Disease in Diabetes Mellitus
- (2016) Xuejing Yue et al. MEDICINE
- Cross-talk between amyloidogenic proteins in type-2 diabetes and Parkinson’s disease
- (2016) Istvan Horvath et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin resistance and Parkinson’s disease: A new target for disease modification?
- (2016) D. Athauda et al. PROGRESS IN NEUROBIOLOGY
- Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson’s disease brain
- (2015) Rosalind F. Roberts et al. BRAIN
- Type 2 diabetes mellitus and biomarkers of neurodegeneration
- (2015) Chris Moran et al. NEUROLOGY
- The molecular mechanism of rotenone-induced α-synuclein aggregation: Emphasizing the role of the calcium/GSK3β pathway
- (2015) Yu-he Yuan et al. TOXICOLOGY LETTERS
- The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration
- (2014) David Heras-Sandoval et al. CELLULAR SIGNALLING
- Diet-induced obesity accelerates the onset of terminal phenotypes in α-synuclein transgenic mice
- (2014) Carola Rotermund et al. JOURNAL OF NEUROCHEMISTRY
- Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study
- (2014) Martina Giuntini et al. PARKINSONISM & RELATED DISORDERS
- Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease
- (2014) Nicolaas I. Bohnen et al. PARKINSONISM & RELATED DISORDERS
- Diabetes is associated with postural instability and gait difficulty in Parkinson disease
- (2013) Vikas Kotagal et al. PARKINSONISM & RELATED DISORDERS
- Shared dysregulated pathways lead to Parkinson's disease and diabetes
- (2013) Jose A. Santiago et al. TRENDS IN MOLECULAR MEDICINE
- Glucose Intolerance, Insulin Resistance, and Pathological Features of Alzheimer Disease in the Baltimore Longitudinal Study of Aging
- (2013) Madhav Thambisetty et al. JAMA Neurology
- Neuropathologic substrates of Parkinson disease dementia
- (2012) David J. Irwin et al. ANNALS OF NEUROLOGY
- Insulin in the Brain: Sources, Localization and Functions
- (2012) Rasoul Ghasemi et al. MOLECULAR NEUROBIOLOGY
- Clinical features of Parkinson disease when onset of diabetes came first: A case-control study
- (2012) E. Cereda et al. NEUROLOGY
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
- (2011) Y. Compta et al. BRAIN
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Systematic review of levodopa dose equivalency reporting in Parkinson's disease
- (2010) Claire L. Tomlinson et al. MOVEMENT DISORDERS
- Diabetes, Alzheimer disease, and vascular dementia: A population-based neuropathologic study
- (2010) S. Ahtiluoto et al. NEUROLOGY
- Different Patterns of Cerebral Injury in Dementia With or Without Diabetes
- (2009) Joshua A. Sonnen ARCHIVES OF NEUROLOGY
- Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
- (2009) Dennis W Dickson et al. LANCET NEUROLOGY
- Parkinson disease and comorbid cerebrovascular disease
- (2009) Wandana Nanhoe-Mahabier et al. Nature Reviews Neurology
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
- (2008) Kurt A. Jellinger et al. ACTA NEUROPATHOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started